Table 1.
Rank | Node | Average link strength |
---|---|---|
1 | Ethics | 4.31 |
2 | Informed Consent | 4.18 |
3 | Research Ethics | 4.12 |
4 | Clinical Trials | 2.82 |
5 | Challenges | 2.42 |
6 | Risks | 2.32 |
7 | Vulnerability | 2.25 |
8 | Clinical Research | 2.22 |
9 | Trials | 2.20 |
10 | Community Engagement | 2.14 |
11 | Health | 2.14 |
12 | Puberty | 2.14 |
13 | Consent | 2.12 |
14 | Bioethics | 2.10 |
15 | Decision Making | 2.08 |
16 | Broad Consent | 2.05 |
17 | Participation | 2.02 |
18 | Ethics Committees | 2.01 |
19 | Care | 2.01 |
20 | Children | 1.99 |
21 | Pregnancy | 1.96 |
22 | Privacy | 1.94 |
23 | Adolescents | 1.94 |
24 | Research | 1.94 |
25 | Capacity | 1.92 |
26 | Dementia | 1.92 |
27 | Issues | 1.89 |
28 | Developing Countries | 1.88 |
29 | People | 1.85 |
30 | Declaration Of Helsinki | 1.83 |
31 | HIV | 1.83 |
32 | Women | 1.82 |
33 | Assent | 1.80 |
34 | CoViD-19 | 1.80 |
35 | Vaccines | 1.78 |
36 | Governance | 1.75 |
37 | Biobanking | 1.72 |
38 | Medical-Research | 1.71 |
39 | Health Research | 1.69 |
40 | Safety | 1.69 |
41 | Data Sharing | 1.68 |
42 | Social Value | 1.68 |
43 | Research Participants | 1.66 |
44 | Interventions | 1.65 |
45 | Design | 1.65 |
46 | Health-Care | 1.65 |
47 | Quality | 1.64 |
48 | Attitudes | 1.63 |
49 | Drugs | 1.63 |
50 | Health Policy | 1.63 |
51 | Qualitative Research | 1.62 |
52 | Parents | 1.61 |
53 | Recruitment | 1.60 |
54 | Participants | 1.60 |